2016
Racial Differences in the Clinical Profile, Causes, and Outcome of Chronic Pancreatitis
Wilcox CM, Sandhu BS, Singh V, Gelrud A, Abberbock JN, Sherman S, Cote GA, Al-Kaade S, Anderson MA, Gardner TB, Lewis MD, Forsmark CE, Guda NM, Romagnuolo J, Baillie J, Amann ST, Muniraj T, Tang G, Conwell DL, Banks PA, Brand RE, Slivka A, Whitcomb D, Yadav D. Racial Differences in the Clinical Profile, Causes, and Outcome of Chronic Pancreatitis. The American Journal Of Gastroenterology 2016, 111: 1488. PMID: 27527745, PMCID: PMC6196097, DOI: 10.1038/ajg.2016.316.Peer-Reviewed Original ResearchMeSH KeywordsAbdominal PainAdultAgedAtrophyBlack or African AmericanCalcinosisCommon Bile Duct DiseasesConstriction, PathologicExocrine Pancreatic InsufficiencyFemaleHumansMaleMiddle AgedPain MeasurementPancreasPancreatic DiseasesPancreatic DuctsPancreatitis, AlcoholicPancreatitis, ChronicPrevalenceProspective StudiesRisk FactorsSex FactorsSmokingTime FactorsWhite PeopleYoung AdultConceptsChronic pancreatitisBlack patientsClinical profileDuration of CPNorth American Pancreatitis StudiesDuration of diseaseAlcoholic chronic pancreatitisProgression of pancreatitisRacial differencesPrior cholecystectomyPain characteristicsAlcohol etiologyCurrent smokersDisease durationSevere painEndoscopic treatmentWhite patientsRisk factorsPancreatic morphologyUS CentersEpidemiologic studiesPatientsAdvanced changesRetrospective dataDetailed questionnaire
2012
Diabetes and pancreatic cancer.
Muniraj T, Chari ST. Diabetes and pancreatic cancer. Minerva Gastroenterology 2012, 58: 331-45. PMID: 23207610, PMCID: PMC3932318.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsBody Mass IndexClinical Trials as TopicDiabetes Mellitus, Type 2Early Detection of CancerEvidence-Based MedicineGlobal HealthGlucose IntoleranceHumansHyperinsulinismHypoglycemic AgentsInsulin GlargineInsulin, Long-ActingMeta-Analysis as TopicMetforminObesityPancreatic NeoplasmsPrevalenceRisk AssessmentRisk FactorsConceptsType 2 diabetesNew-onset diabetesPancreatic cancerPancreatic cancer-associated diabetesAnti-diabetic medicationsDuration of diseasePancreatic cancer patientsYears of ageGlucose toleranceCancer patientsOnset diabetesHigh riskEpidemiological studiesDiabetesCancerAdditional markersModest increaseRiskInverse relationshipRecent studiesMedicationsPatientsDisease